These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 18589179)
1. Rapamycin, mycophenolate mofetil, methylprednisolone, and cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-based conditioning regimen to induce partial tolerance to hind limb allografts without cytoreductive conditioning. Pan H; Wang L; Zhang X; Zhang G; Mai H; Han Y; Guo S Transplant Proc; 2008 Jun; 40(5):1714-21. PubMed ID: 18589179 [TBL] [Abstract][Full Text] [Related]
2. [Adenovirus-mediated CTLA4 immunoglobulin based conditioning for non-myeloablative allogeneic hematopoietic cell transplantation to induce tolerance to hind limb allografts in rats]. Pan H; Wang L; Zhang XD; Mai HX; Liu D; Liu Y; Guo SZ Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(12):937-40. PubMed ID: 19781252 [TBL] [Abstract][Full Text] [Related]
3. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts. Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021 [TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257 [TBL] [Abstract][Full Text] [Related]
5. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts. Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139 [TBL] [Abstract][Full Text] [Related]
6. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Foster RD; Pham S; Li S; Aitouche A Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367 [TBL] [Abstract][Full Text] [Related]
7. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Siemionow MZ; Izycki DM; Zielinski M Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512 [TBL] [Abstract][Full Text] [Related]
8. Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model. Prabhune KA; Gorantla VS; Perez-Abadia G; Francois CG; Vossen M; Laurentin-Perez LA; Breidenbach WC; Wang GG; Anderson GL; Pidwell DJ; Barker JH; Maldonado C Transplantation; 2003 Dec; 76(11):1548-55. PubMed ID: 14702522 [TBL] [Abstract][Full Text] [Related]
9. Role of thymus in operational tolerance induction in limb allograft transplant model. Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246 [TBL] [Abstract][Full Text] [Related]
10. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning. Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314 [TBL] [Abstract][Full Text] [Related]
11. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants. Chen B; Xu H; Corbin DR; Ildstad ST Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444 [TBL] [Abstract][Full Text] [Related]
12. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment. Ozer K; Oke R; Gurunluoglu R; Zielinski M; Izycki D; Prajapati R; Siemionow M Transplantation; 2003 Jan; 75(1):31-6. PubMed ID: 12544867 [TBL] [Abstract][Full Text] [Related]
13. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol. Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363 [TBL] [Abstract][Full Text] [Related]
14. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat. Zhu ZX; Fan LY; Wang Q Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693 [TBL] [Abstract][Full Text] [Related]
16. Vascularized bone grafts within composite tissue allotransplants can autocreate tolerance through mixed chimerism with partial myeloablative conditioning: an experimental study in rats. Huang WC; Lin JY; Wallace CG; Chuang WY; Wei FC; Liao SK Plast Reconstr Surg; 2010 Apr; 125(4):1095-1103. PubMed ID: 20072086 [TBL] [Abstract][Full Text] [Related]
18. Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism. Li S; Thanikachalam M; Pang M; Carreno M; Aitouche A; Pham SM Exp Hematol; 2001 Apr; 29(4):534-41. PubMed ID: 11301194 [TBL] [Abstract][Full Text] [Related]
19. Neuroregeneration in composite tissue allografts: effect of low-dose FK506 and mycophenolate mofetil immunotherapy. Cottrell BL; Perez-Abadia G; Onifer SM; Magnuson DS; Burke DA; Grossi FV; Francois CG; Barker JH; Maldonado C Plast Reconstr Surg; 2006 Sep; 118(3):615-23; discussion 624-5. PubMed ID: 16932168 [TBL] [Abstract][Full Text] [Related]
20. Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells. Esumi T; Inaba M; Ichioka N; Kushida T; Iida H; Ikehara S Transplantation; 2003 Dec; 76(11):1543-8. PubMed ID: 14702521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]